Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | HUMA | Common Stock, par value $0.0001 per share | 18.3M | Aug 26, 2021 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Excludes the Reporting Person's pro rata share of up to 15,000,000 additional shares of the Issuer's Common Stock which may become issuable to the former shareholders of Humacyte, Inc. pursuant to the terms of the Business Combination Agreement dated as of February 17, 2021 by and among the Issuer, Hunter Merger Sub, Inc. and Humacyte, Inc., as to which the Reporting Person disclaims any present beneficial ownership interest. |
F2 | Fresenius Medical Care Holdings, Inc. is an indirect, wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA ("FMC AG & Co. KGaA"). FMC AG & Co. KGaA's address is Else-Kroner Strasse 1, 61352 Bad Homburg, Germany. |